Evidence map›Paper›PMID 27354419›Full record

ArticleJournal of lipid research2016

Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice.

Brian T Palmisano, Thao D Le, Lin Zhu, Yoon Kwang Lee, John M Stafford

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Cardiovascular Benefits of Menopause Hormone Treatment is Age-Dependent.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Sex differences feed into nuclear receptor signaling along the digestive tract.Biochimica et biophysica acta. Molecular basis of disease · 2021
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Brian T PalmisanoTennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN Department of Molecular Physiology and Biophysics Vanderbilt University Medical Center, Nashville, TN.
Thao D LeDepartment of Molecular Physiology and Biophysics Vanderbilt University Medical Center, Nashville, TN.
Lin ZhuDepartment of Molecular Physiology and Biophysics Vanderbilt University Medical Center, Nashville, TN Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Yoon Kwang LeeDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH.
John M StaffordTennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN Department of Molecular Physiology and Biophysics Vanderbilt University Medical Center, Nashville, TN Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN john.stafford@vanderbilt.edu.
Vanderbilt University Medical Center · USNortheast Ohio Medical University · USVA Tennessee Valley Healthcare System · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular RiskR01DK109102 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STAFFORD, JOHN MICHAEL · 2016 to 2024
$3.6M
Hepatic Lipid Mobilization by Nuclear Hormone ReceptorsR01DK093774 · NIDDK · NORTHEAST OHIO MEDICAL UNIVERSITY · PI LEE, YOON-KWANG · 2013 to 2017
$1.5M
The Mechanism of Cetp-Mediated Protection from High-Fat Diet-Induced Insulin ResistanceF30DK104514 · NIDDK · VANDERBILT UNIVERSITY · PI PALMISANO, BRIAN T. · 2014 to 2017
$151k
Cholesteryl ester transfer protein, a novel mediator of insulin sensitivityI01BX002223 · VA · VETERANS HEALTH ADMINISTRATION · PI STAFFORD, JOHN MICHAEL · 2014 to 2017
–
BLRD VA I01 BX002223NIDDK NIH HHS F30 DK104514NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P60 DK020593NIDDK NIH HHS R01 DK093774NIDDK NIH HHS R01 DK109102NIDDK NIH HHS U24 DK059637NIGMS NIH HHS T32 GM007347
6 · The paper itself

Abstract

Elevated plasma TGs increase risk of cardiovascular disease in women. Estrogen treatment raises plasma TGs in women, but molecular mechanisms remain poorly understood. Here we explore the role of cholesteryl ester transfer protein (CETP) in the regulation of TG metabolism in female mice, which naturally lack CETP. In transgenic CETP females, acute estrogen treatment raised plasma TGs 50%, increased TG production, and increased expression of genes involved in VLDL synthesis, but not in nontransgenic littermate females. In CETP females, estrogen enhanced expression of small heterodimer partner (SHP), a nuclear receptor regulating VLDL production. Deletion of liver SHP prevented increases in TG production and expression of genes involved in VLDL synthesis in CETP mice with estrogen treatment. We also examined whether CETP expression had effects on TG metabolism independent of estrogen treatment. CETP increased liver β-oxidation and reduced liver TG content by 60%. Liver estrogen receptor α (ERα) was required for CETP expression to enhance β-oxidation and reduce liver TG content. Thus, CETP alters at least two networks governing TG metabolism, one involving SHP to increase VLDL-TG production in response to estrogen, and another involving ERα to enhance β-oxidation and lower liver TG content. These findings demonstrate a novel role for CETP in estrogen-mediated increases in TG production and a broader role for CETP in TG metabolism.

Indexed as

AnimalsCholesterol Ester Transfer ProteinsEstrogen Receptor alphaEstrogensFemaleLipid MetabolismLiverMetabolic Networks and PathwaysMice, Inbred C57BLMice, TransgenicOxidation-ReductionTriglyceridesCholesterol Ester Transfer ProteinsEstrogen Receptor alphaEstrogensTriglyceridesestrogenestrogen receptor alphalipid and lipoprotein metabolismsmall heterodimer partnertriglyceridesvery low density lipoprotein

Identifiers

PMID27354419
PMCPMC4959869
OpenAlexW2462413218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.